GRAHAM v. TEVA PHARMACEUTICALS USA, INC. et al
EMY GRAHAM |
TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC., D/B/A TEVA WOME'S HEALTH, INC., Teva Pharmaceuticals USA Inc, TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC., Teva Women's Health LLC, The Cooper Companies Inc, Coopersurgical Inc, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. d/b/a Teva Women's Health, Inc. and TEVA WOMEN'S HEALTH INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC. |
1:2021cv00743 |
February 22, 2021 |
US District Court for the Northern District of Georgia |
Leigh Martin May |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on February 23, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 28 ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021. (tmf) |
Civil Case Terminated. (tmf) |
Filing 27 TENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 1/27/21. (aar) |
Filing 26 Case transferred in from District of Indiana Southern; Case Number 1:21-cv-00299. Original file certified copy of transfer order and docket sheet received. |
Filing 25 Transfer Letter to Clerk of the Northern District of Georgia. Case transferred electronically to Northern District of Georgia, IN RE: MDL 2974 on February 22, 2021. (MAC) [Transferred from Indiana Southern on 2/22/2021.] |
Filing 24 CLOSED TRANSFER to the United States District Court for the Northern District of Georgia IN RE: PARAGARD IUD PRODUCTS LIABILITY LITIGATION MDL No. 2974 per CTO-8.(MAC) [Transferred from Indiana Southern on 2/22/2021.] |
Filing 23 MAGISTRATE JUDGE's NOTICE of Availability to Exercise Jurisdiction issued. (JDC) [Transferred from Indiana Southern on 2/22/2021.] |
Filing 22 Case transferred in from District of Pennsylvania Eastern; Case Number 2:20-cv-05245. Original file copy of transfer order and docket sheet received. [Transferred from Indiana Southern on 2/22/2021.] |
Filing 21 STIPULATION AND ORDER THAT THIS ACTION IS TRANSFERRED PURSUANT TO 28 U.S.C. SEC. 1404(a) TO U.S.D.C. FOR THE SOUTHERN DISTRICT OF INDIANA. SIGNED BY HONORABLE HARVEY BARTLE, III ON 12/16/20. (Attachments: #1 Stipulation) 12/16/20 ENTERED AND COPIES E-MAILED. "NOT MAILED TO UNREP PARTIES"(kw, ) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
PLEADING #21 MAILED TO UNREP (JL ) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 20 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Teva Pharmaceuticals USA, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 19 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Teva Women's Health, LLC f/k/a Teva Women's Health, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 18 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Duramed Pharmaceuticals, Inc., a division of Barr Pharmaceuticals, Inc., d/b/a Teva Women's Health, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 17 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Teva Women's Health, Inc., individually and as successor in interest to Duramed Pharmaceuticals, Inc., a division of Barr Pharmaceuticals, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 16 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Teva Women's Health, LLC, individually and as successor in interest to Teva Women's Health, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 15 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead The Cooper Companies, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 14 AFFIDAVIT of Service re: served Civil Action Complaint/Notice to Plead Coopersurgical, Inc. on 10/30/2020 (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 13 NOTICE of Appearance by RANDI KASSAN on behalf of EMY GRAHAM (KASSAN, RANDI) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 12 Original Record together with certified copy of docket entries received from Court of Common Pleas of Philadelphia County. (sg, ) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 11 ANSWER to Complaint by THE COOPER COMPANIES, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 10 ANSWER to Complaint by TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 9 ANSWER to Complaint by TEVA WOMEN'S HEALTH, INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 8 ANSWER to Complaint by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 7 ANSWER to Complaint by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 6 Disclosure Statement Form pursuant to FRCP 7.1 by THE COOPER COMPANIES, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 5 Disclosure Statement Form pursuant to FRCP 7.1 by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 4 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 3 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 2 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA WOMEN'S HEALTH, INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Filing 1 NOTICE OF REMOVAL by THE COOPER COMPANIES, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC., TEVA WOMEN'S HEALTH, INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC. , Court of Common Pleas Philadelphia County, case number 200800200, (Filing fee $ 400 receipt number 0313-14654251), filed by THE COOPER COMPANIES, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC., TEVA WOMEN'S HEALTH, INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC.(RUBENSTEIN, BRIAN) Modified on 10/22/2020 (tjd). [Transferred from Pennsylvania Eastern on 2/4/2021.] [Transferred from Indiana Southern on 2/22/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.